It is well known that IL-6 is one of the main mediators of inflammatory and immune response initiated by infection, and increased levels of IL-6 are present in patients with COVID-19, and are associated with a strong inflammatory response, respiratory failure, necessity for mechanical ventilation and/or intubation, and mortality43,44. This evidence concerns the gene IL6 and COVID-19.